FI921863A - 2-anilinofenylaettiksyraderivat som inhibitorer av pla2 och lipoxigenas. - Google Patents

2-anilinofenylaettiksyraderivat som inhibitorer av pla2 och lipoxigenas. Download PDF

Info

Publication number
FI921863A
FI921863A FI921863A FI921863A FI921863A FI 921863 A FI921863 A FI 921863A FI 921863 A FI921863 A FI 921863A FI 921863 A FI921863 A FI 921863A FI 921863 A FI921863 A FI 921863A
Authority
FI
Finland
Prior art keywords
raderators
lipoxigenas
anilinophenyl
pla2
som
Prior art date
Application number
FI921863A
Other languages
English (en)
Finnish (fi)
Other versions
FI921863A0 (fi
Inventor
Amedeo Arturo Failli
Anthony Frank Kreft Iii
John Henry Musser
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of FI921863A publication Critical patent/FI921863A/fi
Publication of FI921863A0 publication Critical patent/FI921863A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI921863A 1989-10-27 1992-04-24 2-anilinofenylaettiksyraderivat som inhibitorer av pla2 och lipoxigenas. FI921863A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/428,092 US5021576A (en) 1989-10-27 1989-10-27 2-Anilino phenylacetic acid derivatives
PCT/US1990/006253 WO1991006539A1 (en) 1989-10-27 1990-10-27 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase

Publications (2)

Publication Number Publication Date
FI921863A true FI921863A (fi) 1992-04-24
FI921863A0 FI921863A0 (fi) 1992-04-24

Family

ID=23697520

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921863A FI921863A0 (fi) 1989-10-27 1992-04-24 2-anilinofenylaettiksyraderivat som inhibitorer av pla2 och lipoxigenas.

Country Status (12)

Country Link
US (1) US5021576A (pt)
EP (1) EP0523046A1 (pt)
JP (1) JPH05502022A (pt)
KR (1) KR927003528A (pt)
AU (1) AU640429B2 (pt)
BR (1) BR9007789A (pt)
CA (1) CA2067135A1 (pt)
FI (1) FI921863A0 (pt)
HU (1) HUT64751A (pt)
IE (1) IE903873A1 (pt)
PT (1) PT95691A (pt)
WO (1) WO1991006539A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5290798A (en) * 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
IT1256345B (it) * 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
US5374635A (en) * 1993-03-29 1994-12-20 Merck Frosst Canada, Inc. Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis
IT1270203B (it) * 1994-06-09 1997-04-29 Fisons Instr Spa Procedimento e dispositivo per l'introduzione di liquidi in spettrometri di massa mediante nebulizzazione elettrostatica
US6355680B1 (en) 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
US5756518A (en) * 1996-04-02 1998-05-26 Kowa Co., Ltd. Phenylene derivatives
TW200508197A (en) * 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
WO2018214959A1 (zh) 2017-05-26 2018-11-29 南京明德新药研发股份有限公司 作为fxr受体激动剂的内酰胺类化合物
CN115417751A (zh) * 2022-06-13 2022-12-02 中山大学 一种苯环c-h酚羟基化的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
IE58870B1 (en) * 1985-03-08 1993-11-17 Leo Pharm Prod Ltd Pyridine derivatives
EP0219307A3 (en) * 1985-10-16 1987-10-14 Merck Frosst Canada Inc. 2-substituted quinolines
GB2185741B (en) * 1986-01-27 1989-10-25 American Home Prod Heterocyclic sulphonamides
JPH01502755A (ja) * 1987-03-18 1989-09-21 アメリカン・ホーム・プロダクツ・コーポレイション スルホニルカルボキシアミド
JPS6429363A (en) * 1987-07-23 1989-01-31 Yoshitomi Pharmaceutical Heterocyclic derivative
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
IL88433A0 (en) * 1987-11-25 1989-06-30 Merck Frosst Canada Inc Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
AU617386B2 (en) * 1987-12-01 1991-11-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Substituted quinolines
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
PT95690A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados substituidos de acidos benzoilbenzo-, bifenil- e 2-oxazol-alcanoicos, uteis como inibidores de pla2 e da lipoxigenase

Also Published As

Publication number Publication date
IE903873A1 (en) 1991-05-08
WO1991006539A1 (en) 1991-05-16
JPH05502022A (ja) 1993-04-15
BR9007789A (pt) 1992-09-15
HU9201406D0 (en) 1992-07-28
HUT64751A (en) 1994-02-28
CA2067135A1 (en) 1991-04-28
KR927003528A (ko) 1992-12-18
AU6724790A (en) 1991-05-31
US5021576A (en) 1991-06-04
FI921863A0 (fi) 1992-04-24
AU640429B2 (en) 1993-08-26
PT95691A (pt) 1991-09-13
EP0523046A1 (en) 1993-01-20

Similar Documents

Publication Publication Date Title
FI921865A0 (fi) Substituerade indol-, inden-, pyranoindol- och tetrahydrokarbazol-alkansyraderivat som inhibitorer av pla2 och lipoxigenas.
FI904482A0 (fi) Gummikomposition som innehaoller dispergerade poerosa paerlor innehaollande aktiva bestaondsdelar foer tuggummi och foerfarande.
FI915003A0 (fi) Inhibitorer av endotel cellvaext och angiogenesis som innehaoller oligosakkarider.
FI921952A (fi) Foerfarande foer framstaellning av dialkylenpiperidinofoereningar och enantiomerer daerav anvaendbara som laekemedel
FI934373A0 (fi) Fabrikationsprocess av komposittraod och kompositprodukter som faotts avnaemnda traoden
FI922454A (fi) Peptider och antikroppar som inhiberar integrinligandbindning.
FI904729A0 (fi) Inhibitorer av retrovirala proteaser.
FI923558A0 (fi) Tetrahydroindazol-, tetrahydrocyklo -pentapyrazol- och hexahydrocykloheptapyrazolfoereningar och deras anvaendning som inhibitorer av hmg-coa-reduktas.
FI935767A0 (fi) Foerfarande och anordning foer centrering av en stock och foer tillfoeringav en stock som skall centreras
FI923185A0 (fi) Foerfarande och anordning foer framstaellning av fogloesa band- och traodoeglor och deras anvaendning som kapverktyg i band- och traodsaogar.
FI923756A (fi) Polyolefinkompositioner som omfattar glycerolmonoestrar av c20-24-fettsyror och daerav framstaellda skumprodukter
FI921863A0 (fi) 2-anilinofenylaettiksyraderivat som inhibitorer av pla2 och lipoxigenas.
FI900045A (fi) Proteasfattiga gram-positiva bakterier och anvaendning daerav som vaerdorganism foer framstaellning av rekombinationsprodukter.
FI913138A0 (fi) Foerfarande foer framstaellning av b -laktamer som innehaoller aminotiazol(iminooxiaettiksyra) aettiksyrasidokedjor och mellanprodukter daerav.
FI921864A (fi) Substituerade bensoylbenzen-, bifenyl- och 2-oxazolalkansyraderivat som inhibitorer av pla2 och lipoxigenas.
FI915609A (fi) Foerfarande och anordning foer styrning av en m-pulsvaexelriktaranordning som bestaor av en mastervaexelriktare och aotminstone en slavvaexelriktare.
FI914776A (fi) Inhibitorer foer bildning av tumoernekrosfaktor, foerfarande foer deras framstaellning och anvaendning daerav.
FI901555A0 (fi) Intranasal administrering av fysostigmin och arekolin.
FI651U1 (fi) Byggnad som omfattar flera vaoningar och som bestaor av moduler
FI650U1 (fi) Byggnad som omfattar flera vaoningar och som bestaor av moduler
FI935932A0 (fi) Anordning som underlaettar saettning och omsaettning av vaextplantor
FI934005A0 (fi) Foerfarande foer visning av parkeringstid i en betalanordning foer parkering och en betalanordning foer parkering som visar parkeringstid
FI921170A0 (fi) Foerfarande foer detektering av taendarmekanismer och foerkoncentrering av gaser som avdunstas fraon maetobjektet.
FI960262A0 (fi) Stoedanordning som foerbaettrar kryckkaeppars och spatserkaeppars hanterbarhet
FI913241A (fi) Foerfarande foer anvaendning av fjaeder baode som fjaeder och begraensare ochanordning foer tillaempning av foerfarandet

Legal Events

Date Code Title Description
FD Application lapsed